Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies

INTRODUCTION: A novel, red-shifted bioluminescence imaging (BLI) system called AkaBLI has been recently developed for cell tracking in preclinical models and to date, limited data is available on how it performs in relation to existing systems. PURPOSE: To systematically compare the performance of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Amadeo, Francesco, Plagge, Antonius, Chacko, Anitta, Wilm, Bettina, Hanson, Vivien, Liptrott, Neill, Murray, Patricia, Taylor, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803776/
https://www.ncbi.nlm.nih.gov/pubmed/34313817
http://dx.doi.org/10.1007/s00259-021-05439-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803776/
https://www.ncbi.nlm.nih.gov/pubmed/34313817
http://dx.doi.org/10.1007/s00259-021-05439-4

Ejemplares similares